XLI News Alert Industrial Select Sector SPDR (XLI) 57.26 12/06/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 7, 2014 at 12:13 AM

Industrial Select Sector SPDR (XLI) 57.26 $XLI

U.S. Manufacturing: A Strong Head Of Steam
Gordon Grob - at Seeking Alpha - Fri Dec 05, 6:14AM CST

IYJ: 107.71 (+0.17), GE: 26.01 (-0.08), UTX: 111.29 (+0.08), XLI: 57.26 (+0.13), UNP: 118.61 (-1.15)

Sector Returns For November 2014
Brian Gilmartin, CFA - Seeking Alpha - Mon Dec 01, 3:58PM CST
Since so much of our earnings work is sector-related, here is a quick recap of sector returns for November ’14, both from the S&P 500 perspective and the SPDR perspective. Note: The first column is the S&P 500 sector return, per The...
XTL: 57.44 (+0.38), XLB: 49.77 (-0.04), XLP: 48.85 (+0.09), SPY: 208.00 (+0.34), XLY: 71.53 (+0.16), XLK: 42.12 (-0.05), XLI: 57.26 (+0.13), XLU: 45.87 (-0.36), XLF: 24.82 (+0.22), XLV: 70.79 (+0.56), XLE: 80.28 (-0.97)

Stronger Than Expected ISM Manufacturing
Bespoke Investment Group - Seeking Alpha - Mon Dec 01, 1:34PM CST
Today's release of the ISM Manufacturing report for the month of November confirmed some of the recent weakness that we have been seeing in the regional Fed manufacturing surveys, as the headline reading showed a decline of 0.3 points, falling from...
IYJ: 107.71 (+0.17), XLI: 57.26 (+0.13), FIDU: 29.02 (+0.06), VIS: 108.87 (+0.35), FXR: 30.77 (+0.14)

S&P 500 Weekly Earnings Update: Could December See Upside Earnings Surprises From Crude Decline Beneficiaries?
Brian Gilmartin, CFA - at Seeking Alpha - Sun Nov 30, 11:02AM CST
Per Thomson Reuters "This Week in Earnings", the "forward, 4-quarter" earnings estimate for the S&P 500, fell to $126.15, from last week's $126.48. The PE ratio on the forward estimate is 16.4(x). The PEG ratio remains at...
XLB: 49.77 (-0.04), XLP: 48.85 (+0.09), SPY: 208.00 (+0.34), QQQ: 105.38 (+0.01), XLY: 71.53 (+0.16), DIA: 179.51 (+0.68), XLK: 42.12 (-0.05), XLI: 57.26 (+0.13), IWM: 117.69 (+0.88), XLU: 45.87 (-0.36), XLF: 24.82 (+0.22), XLE: 80.28 (-0.97)

What did the billionaires do in Q3?
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 1:46PM CST

XLB: 49.77 (-0.04), MON: 120.86 (-0.23), DAL: 47.28 (+0.86), GOOG: 525.26 (-12.05), HUM: 144.32 (+3.20), NOV: 66.89 (-0.46), MSI: 65.00 (-0.20), WHR: 188.83 (+0.57), XLP: 48.85 (+0.09), RIG: 18.72 (+0.04), THC: 51.79 (+3.37), WMB: 50.04 (-1.09), ABBV: 69.71 (+0.14), XLI: 57.26 (+0.13), XLF: 24.82 (+0.22), MSFT: 48.42 (-0.42), APD: 146.73 (+0.93), APC: 79.07 (-0.31), XLE: 80.28 (-0.97), MCK: 212.63 (+0.81), TMO: 128.54 (+0.15), FB: 76.36 (+1.12), XLY: 71.53 (+0.16), ICE: 224.77 (-2.28), MHFI: 93.71 (+0.35), MAS: 24.87 (+0.09), XLV: 70.79 (+0.56), NFLX: 350.92 (+0.32), CI: 104.71 (+1.52), GM: 33.93 (+0.84), IBLN: 26.18 (+0.12), GPS: 40.74 (+0.18), AIG: 55.33 (+0.16), CMCSA: 56.34 (-0.04), CTSH: 53.15 (-0.37), CBS: 55.09 (+0.24)

S&P 500 Weekly Earnings Update: Q3 '14 Earnings Were Strong; Q4 '14 Will Also Be Very Healthy (Despite Energy)
Brian Gilmartin, CFA - Seeking Alpha - Mon Nov 24, 6:28AM CST
Per Thomson Reuters, the “forward 4-quarter” estimate last week fell slightly to $126.48 from the previous week’s $126.64. The metrics as of 11/21/14’s close: SP 500: 2,063.50 P.E ratio: 16.3(x) PEG ratio: ...
XTL: 57.44 (+0.38), RXI: 86.48 (+0.10), KXI: 91.83 (-0.06), IYJ: 107.71 (+0.17), DBE: 20.21 (-0.14), XLB: 49.77 (-0.04), IYH: 148.80 (+1.17), IPS: 39.23 (+0.11), IPD: 38.83 (+0.23), IYM: 85.26 (unch), FXU: 24.34 (-0.12), XLU: 45.87 (-0.36), IYF: 90.52 (+0.76), XLV: 70.79 (+0.56), IYZ: 29.77 (+0.05), SPY: 208.00 (+0.34), XLK: 42.12 (-0.05), JJE: 12.90 (+0.30), XLI: 57.26 (+0.13), XLF: 24.82 (+0.22), IYW: 106.24 (unch)

Perspective On The U.S. Industrial Sector
FX Analyst - at Seeking Alpha - Sat Nov 22, 11:07AM CST

IYJ: 107.71 (+0.17), RGI: 90.83 (+0.23), UXI: 117.66 (-0.23), AIRR: 18.41 (+0.15), SIJ: 42.46 (+0.25), XLI: 57.26 (+0.13), FIDU: 29.02 (+0.06), VIS: 108.87 (+0.35), FXR: 30.77 (+0.14)

ETF Winners From Q3 Earnings Season
Zacks Funds - at Seeking Alpha - Tue Nov 18, 9:54PM CST
The Q3 2014 earnings season appears to be a decent one, with no big surprises or huge disappointments. This is especially true as total earnings for the S&P 500 companies that have reported so far are up 6.7% on an annual basis with a beat ratio...
BBH: 119.06 (+1.01), XLI: 57.26 (+0.13), IYT: 164.57 (+0.64)

U.S. Industrial Output Slumps In October
James Picerno - Seeking Alpha - Mon Nov 17, 12:48PM CST
Industrial activity dipped 0.1 percent last month, clawing back a portion of the 0.8 percent rise in the previous month, the Federal Reserve reports. The slump surprised analysts, who were expecting a 0.3% gain, according to Econoday.com's...
IYJ: 107.71 (+0.17), SPY: 208.00 (+0.34), XLI: 57.26 (+0.13), FIDU: 29.02 (+0.06), VIS: 108.87 (+0.35), FXR: 30.77 (+0.14)

ETF Winners from Q3 Earnings Season - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 11, 1:00PM CST
These ETFs emerged as a winner in Q3 earnings season.
BBH: 119.06 (+1.01), XLI: 57.26 (+0.13), IYT: 164.57 (+0.64)

The Best Offense Is A Good Defense
Eric Parnell, CFA - Seeking Alpha - Sat Nov 08, 8:36AM CST
What a difference a few weeks make. Stocks are once again in rally mode and bullishness is back on the street. After bottoming back on October 15, stocks as measured by the S&P 500 Index have rallied an impressive +11.6% to advance to fresh new...
XLB: 49.77 (-0.04), BDX: 139.15 (-1.53), SPLV: 37.70 (unch), DAL: 47.28 (+0.86), XLY: 71.53 (+0.16), BBY: 35.63 (-0.45), XLU: 45.87 (-0.36), SO: 47.54 (-0.37), XLV: 70.79 (+0.56), YHOO: 50.99 (+0.58), XLP: 48.85 (+0.09), SPY: 208.00 (+0.34), SPHB: 34.62 (+0.13), XLK: 42.12 (-0.05), PG: 90.38 (-0.20), XLI: 57.26 (+0.13), XLE: 80.28 (-0.97)

Pause For A Cause: A 3-Month Outlook On The S&P 500 And U.S. 10-Year Yield
Cerebro1 - at Seeking Alpha - Wed Nov 05, 2:44PM CST

SPY: 208.00 (+0.34), IEF: 105.10 (-0.59), XLY: 71.53 (+0.16), XLK: 42.12 (-0.05), XLI: 57.26 (+0.13), XLU: 45.87 (-0.36), XLF: 24.82 (+0.22), XLV: 70.79 (+0.56)

A Valuation Snapshot By Sectors
Fred Piard - at Seeking Alpha - Wed Nov 05, 9:09AM CST

XLB: 49.77 (-0.04), XLP: 48.85 (+0.09), XLY: 71.53 (+0.16), XLK: 42.12 (-0.05), XLI: 57.26 (+0.13), XLU: 45.87 (-0.36), XLF: 24.82 (+0.22), XLV: 70.79 (+0.56), XLE: 80.28 (-0.97)

VIS And VAW Come Together
Scott Arterburn - at Seeking Alpha - Tue Nov 04, 1:56PM CST

XLB: 49.77 (-0.04), SPY: 208.00 (+0.34), XLI: 57.26 (+0.13), VIS: 108.87 (+0.35), VAW: 111.14 (+0.09)

Durable Goods Cycles
Joseph Calhoun - Seeking Alpha - Tue Oct 28, 5:28PM CDT
By Jeffrey P. Snider The unfortunately established narrative for all economic accounts in 2014 relates (still) to the depressing winter earlier in the year and "better" from there. At first glance, the latest figures on durable goods seem...
IYJ: 107.71 (+0.17), SPY: 208.00 (+0.34), XLI: 57.26 (+0.13), VIS: 108.87 (+0.35)

Transport ETFs Drive Up on Robust Q3 Earnings - ETF News And Commentary
Sweta Killa - ZACKS - Tue Oct 28, 2:00PM CDT
Transport ETFs surged in double digits on inspiring Q3 earnings results.
XTN: 107.30 (+0.37), DAL: 47.28 (+0.86), KSU: 117.30 (-1.15), DIA: 179.51 (+0.68), XLI: 57.26 (+0.13), CSX: 36.95 (+0.41), IYT: 164.57 (+0.64), UNP: 118.61 (-1.15), UPS: 110.98 (+0.55), UAL: 63.03 (+1.28)

Strong Industrial Stock Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Oct 27, 9:00AM CDT
With strength in earnings season from companies like CAT, UNP, and MMM, it could be time for these industrial ETFs.
MMM: 162.27 (+0.01), IYJ: 107.71 (+0.17), CAT: 98.78 (-0.89), XLI: 57.26 (+0.13), VIS: 108.87 (+0.35), UNP: 118.61 (-1.15)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...